Table_1_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-... by Jie Zhang (64655)

“…</p>Results<p>The study included 37 randomized controlled trials with 17,410 participants and 20 interventions. According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”

Image_1_Dazhu Hongjingtian Preparation as Adjuvant Therapy for Unstable Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials.TIF by Changfeng Man (5744663)

“…Adjuvant treatment with DZHJT significantly decreased ≥80% reduction in the frequency of angina attacks [risk ratio (RR) 1.57; 95% CI 1.36–1.81], weekly frequency of angina attacks [mean difference (MD) −1.03 times; 95% confidence interval (CI) −1.51 to −0.55], marked improved abnormal electrocardiogram (RR 1.46; 95% CI 1.23–1.74). …”

Image_1_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-... by Jie Zhang (64655)

“…</p>Results<p>The study included 37 randomized controlled trials with 17,410 participants and 20 interventions. According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”

Data_Sheet_1_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network... by Jie Zhang (64655)

“…</p>Results<p>The study included 37 randomized controlled trials with 17,410 participants and 20 interventions. According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”

Table_2_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-... by Jie Zhang (64655)

“…</p>Results<p>The study included 37 randomized controlled trials with 17,410 participants and 20 interventions. According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”

Table_3_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-... by Jie Zhang (64655)

“…</p>Results<p>The study included 37 randomized controlled trials with 17,410 participants and 20 interventions. According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”

Table_4_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-... by Jie Zhang (64655)

“…</p>Results<p>The study included 37 randomized controlled trials with 17,410 participants and 20 interventions. According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”

Table_5_The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-... by Jie Zhang (64655)

“…</p>Results<p>The study included 37 randomized controlled trials with 17,410 participants and 20 interventions. According to the pairwise meta-analysis, statins significantly decreased CRP levels compared to controls (weighted mean difference [WMD] = −0.97, 95% confidence interval [CI] [−1.31, −0.64], P < 0.0001). …”

Image_3_Dazhu Hongjingtian Preparation as Adjuvant Therapy for Unstable Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials.TIF by Changfeng Man (5744663)

“…Adjuvant treatment with DZHJT significantly decreased ≥80% reduction in the frequency of angina attacks [risk ratio (RR) 1.57; 95% CI 1.36–1.81], weekly frequency of angina attacks [mean difference (MD) −1.03 times; 95% confidence interval (CI) −1.51 to −0.55], marked improved abnormal electrocardiogram (RR 1.46; 95% CI 1.23–1.74). …”

Data_Sheet_1_Dazhu Hongjingtian Preparation as Adjuvant Therapy for Unstable Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials.doc by Changfeng Man (5744663)

“…Adjuvant treatment with DZHJT significantly decreased ≥80% reduction in the frequency of angina attacks [risk ratio (RR) 1.57; 95% CI 1.36–1.81], weekly frequency of angina attacks [mean difference (MD) −1.03 times; 95% confidence interval (CI) −1.51 to −0.55], marked improved abnormal electrocardiogram (RR 1.46; 95% CI 1.23–1.74). …”

Table 1_Geochronology and metamorphic evolution of the biotite-plagioclase gneisses from the Luanxian Group in eastern Hebei, North China Craton.xlsx by Daji Zu (21803648)

“…Post-peak decompression-cooling is defined by decreasing X_Ti from core to rim in matrix biotite, collectively defining a clockwise P–T path. …”

Flow cytometric analysis of B cell populations. by Marc C. Levesque (262285)

“…In cells from terminal ileal biopsies, uninfected participants had a mean±standard error of the mean 29.9%±7.0% of naïve B cells that were decreased to 15.7%±8.9% in AHI patients. …”

<b>PathoBiocheModelling to manage Unknowns in Neurodevelopmental Cofactor Disorders</b> by Yuliya Buinitskaya (8680986)

“…Since the vitamin levels including FAD were normal, a genetic cause was suspected. Moreover, we also found decreased activity of some other FAD dependent enzymes such as Aconitase. …”

Qualitative and quantitative assessment of manually re-evaluated genomes. by Abhinay Ramaprasad (521263)

“…We find a ~20% increase in genes with functional domains after curation in <i>Tg</i>VEG and ~10% in <i>Nc</i>LIV genome.…”

Intravascular Immune Surveillance by CXCR6⁺ NKT Cells Patrolling Liver Sinusoids by Frederic Geissmann (75)

“…<div><p>We examined the in vivo behavior of liver natural killer T cells (NKT cells) by intravital fluorescence microscopic imaging of mice in which a green fluorescent protein cDNA was used to replace the gene encoding the chemokine receptor CXCR6. …”

Identifiability analysis for the logistic, radial-death, and Greenspan models. by Alexander P. Browning (6908948)

“…Decreasing the confidence level (i.e. from 95% to 99%) lowers this threshold. …”

Countermeasure evaluation and ABM topical sensitivity. by Prateek Puri (18864381)

“…When a user is blocked in the ABM, they cannot infect other users. (B) We simulate an inoculation campaign within our ABM by running a set of simulations where a variable fraction of users within a community (x-axis) has their output infection probabilities decreased by ~20%. …”

PMS exhibited therapeutic effects on T2DM mice. by Hongmin Zhao (20710544)

Production of serotonin inhibits H₂O₂-induced food leaving. by Jodie A. Schiffer (11873352)

Norgestrel-supplemented diet significantly protects against photoreceptor cell death out to P40 in the rd10 retina. by Sarah L. Roche (452321)

“…Norgestrel treatment (NORG diet) decreased TUNEL-positive staining in the central P15 and P20 retina compared to control mice (Control diet). …”